Okada, Hideshi <br/><br/>
Combined therapy with cardioprotective cytokine administration and antiapoptotic gene transfer in postinfarction heart failure.  [electronic resource] 

 -  American journal of physiology. Heart and circulatory physiology  Mar 2009 
 - H616-26 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0363-6135 
<br/><br/><label>Standard No.: </label>10.1152/ajpheart.01147.2008  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenoviridae--genetics<br/>Animals<br/>Apoptosis--drug effects<br/>Cardiotonic Agents--pharmacology<br/>Cell Proliferation--drug effects<br/>Cells, Cultured<br/>Combined Modality Therapy<br/>Disease Models, Animal<br/>Fibroblasts--drug effects<br/>Fibrosis<br/>Gene Transfer Techniques<br/>Genetic Therapy<br/>Genetic Vectors<br/>Granulation Tissue--drug effects<br/>Granulocyte Colony-Stimulating Factor--pharmacology<br/>Heart Failure--etiology<br/>Humans<br/>Lenograstim<br/>Male<br/>Mice<br/>Mice, Inbred C57BL<br/>Myocardial Contraction--drug effects<br/>Myocardial Infarction--complications<br/>Myocardium--metabolism<br/>Myocytes, Cardiac--drug effects<br/>Proto-Oncogene Proteins c-bcl-2--metabolism<br/>Recombinant Proteins--pharmacology<br/>Regeneration--drug effects<br/>Time Factors<br/>Ventricular Dysfunction, Left--etiology<br/>Ventricular Remodeling--drug effects<br/>bcl-2-Associated X Protein--metabolism<br/>fas Receptor--genetics